BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/9/2026 6:58:24 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-03-05 00:26 |
|
Peer-Review Started |
|
2026-03-05 23:55 |
|
First Decision by Editorial Office Director |
|
2026-03-27 10:31 |
|
Return for Revision |
|
2026-03-27 10:31 |
|
Revised |
|
2026-04-09 08:51 |
|
Publication Fee Transferred |
|
2026-04-13 02:59 |
|
Second Decision by Editor |
|
2026-05-18 02:55 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-09 06:31 |
|
Articles in Press |
|
2026-06-09 06:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-23 09:53 |
|
Publish the Manuscript Online |
|
2026-07-09 06:58 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Observational Study |
| Article Title |
Association between the high-sensitivity C-reactive protein-triglyceride-glucose index and metabolic dysfunction-associated steatotic liver disease across different glycemic states
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Hao Zhang, Rong-Dong-Qing Shi, Kui Chen, Xian-Ming Li, Gui-Hua Yu, Xin-Yuan Ye, Qing Xu, Yu Ding and Si-Hui Luo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82300904 |
| National Natural Science Foundation of China |
82100857 |
|
| Corresponding Author |
Si-Hui Luo, Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, 17 Lujiang Road, Hefei 230000, Anhui Province, China. luosihui@ustc.edu.cn |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; High-sensitivity C-reactive protein-triglyceride-glucose index; Glycemic status; Prediabetes; Diabetes; Cross-sectional study |
| Core Tip |
This large cross-sectional study (n = 7413) evaluated the high-sensitivity C-reactive protein-triglyceride-glucose index (CTI) as a non-invasive biomarker for metabolic dysfunction-associated steatotic liver disease (MASLD) across glycemic states. The CTI showed robust diagnostic performance (area under the curve: 0.808) with strongest predictive value in normal glucose regulation (adjusted OR = 3.07) and prediabetes (OR = 3.26), but weaker association in diabetes (OR = 1.58). Optimal CTI thresholds increased progressively from normoglycemia to diabetes (8.596, 8.908, 9.456, respectively). These findings suggest CTI is a practical biomarker for early MASLD risk identification, particularly in individuals without overt diabetes. |
| Publish Date |
2026-07-09 06:58 |
| Citation |
Zhang WH, Shi RDQ, Chen K, Li XM, Yu GH, Ye XY, Xu Q, Ding Y, Luo SH. Association between the high-sensitivity C-reactive protein-triglyceride-glucose index and metabolic dysfunction-associated steatotic liver disease across different glycemic states. World J Diabetes 2026; 17(7): 120647
|
| URL |
https://www.wjgnet.com/1948-9358/full/v17/i7/120647.htm |
| DOI |
https://doi.org/10.4239/wjd.120647 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
